At Inke S.A. we are dedicated to the development and manufacture of high-quality APIs, specializing in complex synthesis processes, particularly for respiratory therapies.

With over 25 years of experience in micronisation and based in Barcelona, Spain, Inke has been at the forefront of pharmaceutical innovation since 1980. We are a trusted partner in the global pharmaceutical industry, supplying APIs to markets across Europe, the US, Japan, and more. Our commitment to quality and regulatory excellence is reflected in our successful inspections by major global authorities, including the US-FDA, with our most recent inspection in April 2019.

Our portfolio reflects our deep commitment to innovation, patent leadership, and scientific excellence in the pharmaceutical field. We develop, patent, and implement own synthesis routes, ensuring compliance with stringent regulatory requirements and delivering tailor-made solutions for our customers.

In addition to our micronisation expertise, we provide comprehensive support for the regulatory process, including Drug Master Files (DMFs), Certificates of Suitability (CEPs), and full technical assistance. Our R&D initiatives and advanced laboratory facilities make us a leading player in the respiratory therapeutics space, always pushing boundaries to meet customer and patient needs.

To learn more about our expertise in inhalation therapies, please get in touch with us by sending an email to contact-inke@inke.es

Therapeutics

Pharmaceutical

Life Sciences

Inke

Miquel Bachs Taberner

Jorge Llorens Noguera

Carlos Royo Escriche

Jakob Rydberg

Laura Sánchez Salguero

Francesc Matas

Ferran Font

Arnau Novell

Inke

Org chart

Teams

Offices

Similar companies